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ABSTRACT 
MODIFICATIONS OF MYOFILAMENT STRUCTURE AND FUNCTION DURING 
GLOBAL MYOCARDIAL ISCHEMIA 
SEPTEMBER 2016 
MIKE K. WOODWARD, B.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
M.S., CANDIDATE, UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor Edward P. Debold 
Cardiac arrest is a prevalent condition with a poor prognosis, attributable in part 
to persistent myocardial dysfunction following resuscitation. The molecular basis of this 
dysfunction remains unclear. We induced cardiac arrest in a porcine model of acute 
sudden death and assessed the impact of ischemia and reperfusion on the molecular 
function of isolated cardiac contractile proteins. Cardiac arrest was electrically induced, 
left untreated for 12 min, and followed by a resuscitation protocol. With successful 
resuscitations, the heart was reperfused for 2 h (IR2) and the muscle harvested. In failed 
resuscitations, tissue samples were taken following the failed efforts (IDNR). Actin 
filament velocity, using myosin isolated from IR2 or IDNR cardiac tissue, was nearly 
identical to myosin from the control tissue in a motility assay. However, both maximal 
velocity (25% faster than control) and Ca2+ sensitivity (pCa50 6.57 ± 0.04 IDNR vs. 6.34 
± 0.07 control) were significantly (p < 0.05) enhanced using native thin filaments (actin, 
troponin, and tropomyosin) from IDNR samples, suggesting that the enhanced velocity is 
mediated through an alteration in muscle regulatory proteins (troponin and tropomyosin). 
Mass spectrometry analysis showed that only samples from the IR2 had an increase in 
total phosphorylation levels of troponin (Tn) and tropomyosin (Tm), but both IR2 and 
IDNR samples demonstrated a significant shift from mono-phosphorylated to bis-
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phosphorylated forms of the inhibitory subunit of Tn (TnI) compared to control. This 
suggests that the shift to bis-phosphorylation of TnI is associated with the enhanced 
function in IDNR, but this effect may be attenuated when phosphorylation of Tm is 
increased in tandem, as was observed for IR2. There are likely many other molecular 
changes induced following cardiac arrest, but to our knowledge, these data provide the 
first evidence that this form cardiac arrest can alter the in vitro function of the cardiac 
contractile proteins.  
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CHAPTER I 
INTRODUCTION 
Research must be conducted to discover a molecular basis for the myocardial 
dysfunction that occurs due to global ischemia. Sudden cardiac arrest is typically 
precipitated by ventricular fibrillation or pulseless ventricular tachycardia, a life-
threatening condition characterized by an abrupt loss of blood flow resulting in 
progressive global ischemia [Neumar et al.,  2008]. The earliest biochemical changes that 
occur in the myocytes during an ischemic event are the accumulation of metabolites 
including: hydrogen ions (H+), inorganic phosphate (Pi), and adenosine diphosphate 
(ADP) [Bolli and Marban,  1999  ,  Allen and Orchard,  1987  ,  Schaefer et al.,  1990  ,  
Elliot et al.,  1992]. These molecules exert direct depressive effects on the mechanical 
function of the contractile apparatus, however levels of these molecules quickly (< 5 
minutes) return to normal with return of blood flow and therefore cannot explain the 
persistent decrease in cardiac function [Bolli and Marban,  1999  ,  Allen and Orchard,  
1987  ,  Schaefer et al.,  1990  ,  Elliot et al.,  1992]. At a molecular level, force and 
power in the heart result from the calcium (Ca2+) dependent sliding of actin-based thin 
filaments past myosin-thick filaments in a process driven by the hydrolysis of adenosine 
triphosphate (ATP). Thus, the more likely cause of post-arrest myocardial dysfunction 
are the persistent structural modifications of the contractile apparatus similar to those 
which occur in models of localized ischemia [Rao et al.,  2007]. Several forms of changes 
have been seen including but not limited to: the contractile proteins incurring oxidative 
damage [Tiago et al.,  2006  ,  Alvarez and Radi.,  2003  ,  Dean et al.,  1997], post-
translational modifications [Rao et al.,  2007  ,  Han and Ogut,  2010  ,  Han and Ogut,  
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2011  ,  Christopher et al.,  2009], or degradation by proteases [Dean et al.,  1997  ,  
Sawicki et al.,  2005  ,  Day et al.,  2007] as a result of ischemia.  
Successful resuscitation with return of spontaneous circulation (ROSC) can 
restore blood flow to near normal levels within minutes of an event, however the 
prognosis for revived patients remains quite poor with only ~10 % surviving to hospital 
discharge if it occurs outside of a hospital [Eisenberg and Mengert,  2001  ,  
Schoenenberger et al.,  1994] and only improves to 23% if it occurs in a hospital setting 
[Roger et al.,  2012]. After resuscitation many patients experience “postcardiac arrest 
syndrome,” characterized by a persistent mechanical myocardial dysfunction in the 
absence of large morphological changes [Kern,  2002], which is believed to be a leading 
cause of the high morbidity and mortality following cardiac arrest [Neumar et al.,  2008]. 
The most notable structural changes that have been observed include post-translational 
modifications to myosin and troponin subunit I (TnI), such as cleavage, oxidative 
damage, or phosphorylation, which may have resulted in the marked decrease in 
contractile function [Monasky et al., 2011  ,  Rao et al.,  2007].  
In both research and clinical settings the serum levels of TnT (the subunit that 
interacts with tropomyosin (Tm)) and TnI can also be measured to determine the severity 
of myocardial damage and necrosis that caused the release of Tn into the serum [Scheitz 
et al.,  2011  ,  Park et al.,  2011  ,  Lotze et al.,  2011]. However the molecular basis of 
the persistent mechanical dysfunction are unclear and thus the extremely poor prognosis 
is unclear [Chalkias and Xanthos,  2012  ,  Bolli and Marban,  1999]. For example it is 
unknown if cardiac arrest directly affects the function of contractile proteins that give rise 
to the force and power generating capacity of the heart [Chalkias and Xanthos,  2012].  
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This induced global ischemia closely mirrors a clinical setting where human 
patients whose heart contractions have ceased and have been revived before arriving at 
the hospital. These patients still have decreased contractile function post 
resuscitation/reperfusion and high mortality rates. Therefore this work could have 
important implications for understanding the molecular basis for this highly prevalent 
condition. These types of investigations could provide crucial insight for the development 
of novel treatments for this deadly condition.  
Specific Aims 
The goal of this study was to determine the effect of ischemia and ischemia-
reperfusion injury on the function of contractile proteins that help explain the long term 
depression in cardiac function following these types of events. A more effective 
understanding of the molecular basis for the depressed cardiac function could potentially 
lead to improvements in understanding how to improve human heart health. We 
hypothesized that the isolated cardiac myosin from post-ischemia-reperfusion animals 
would have a decreased ability to translocate actin filaments and that this would be in 
part attributable to effects on myosin. Also native thin filaments (NTF), composed of 
actin and the regulatory proteins Tn and Tm, were isolated and examined since previous 
studies implicated regulatory protein damage (cleavage and post-translational 
modifications). We also hypothesized that if there were any alterations (cleavage or 
phosphorylation) to these regulatory proteins, then it would result in an altered response 
to Ca2+ and would likely result in decreased contractility.  
 To accomplish these goals we isolated the myosin and NTF from cardiac tissue 
samples and used the in vitro motility assay to determine if there was any change in 
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function compared to control (hearts that did not undergo ischemia and/or reperfusion). 
The in vitro motility assay allowed us to view actin filaments and NTF as they 
translocated over a bed of isolated cardiac myosin and flow-cell conditions were altered 
to examine their impact. This allowed us to analyze the velocity, determine a change in 
contractile function, and infer a mechanistic change that could have resulted in the altered 
function. Also specific gel electrophoresis techniques were attempted to determine if 
there were changes in the phosphorylation status of certain proteins or if cleavage had 
occurred. These results were inconclusive and so we employed electrospray ionization 
liquid chromatography tandem mass spectrometry to gain much more accurate data on 
changes in phosphorylation and cleavage.  
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CHAPTER II 
LITERATURE REVIEW 
Calcium and Actomyosin Interaction 
 Cardiac muscle is able to produce force because of the cyclical interaction of actin 
and myosin, the two key contractile proteins. Myosin is a molecular motor which can 
bind to actin and hydrolyze ATP to produce mechanical force or generate motion. Figure 
1 displays how the binding of ATP, binding of actin, and hydrolysis follow a cyclic 
interaction allowing for myosin to bind, produce force, and release from actin to reinitiate 
the cycle. The displacement caused by myosin’s power-stroke thus causes the thick and 
thin filament to slide over each other, which causes the contraction of muscle tissue.  
 
 
 
Figure 1. The Crossbridge Cycle. A schematic representation of the crossbridge cycle 
with d as the displacement and ton as the duration that the myosin is strongly bound to 
actin, which is composed of tADP  and trigor. The duration of time the cycle when ADP 
bound myosin is bound to actin is tADP. trigor is the time at which actin and myosin are 
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strongly bound in rigor awaiting the binding of ATP to allow the release of myosin from 
actin. Originally from [Debold et al.,  2011]. 
 
 
This interaction is closely regulated in a Ca2+ dependent manner through Ca2+ 
interacting with Tn, regulating the position of Tm on actin [Ebashi and Endo,  1968  ,  
Gordon et al.,  2000  ,  Heeley,  1994]. Figure 2 illustrates how Tn unbound to Ca2+ holds 
Tm in a position that prevents strong stereo-specific binding of myosin to actin. Ca2+ 
binds to the TnC subunit and exposes a hydrophobic section of its N-terminus. This 
hydrophobic pocket then allows the switch domain of TnI (the inhibitory subunit) to bind, 
which allows Tm to move into the actin helix groove ultimately causing Tm to unblock 
the myosin binding sites on actin.  
 
 
Figure 2. Troponin conformation at low [Ca2+] and high [Ca2+]. The conformational 
change that occurs in TnC and TnI’s C-terminal tail, which allows Tm to move into the 
groove of the actin-helix and thus opens the myosin binding sites on actin. The heart 
cycles between: A) low [Ca2+] in diastole and B) high [Ca2+] in systole. Originally from 
[Day et al.,  2007].  
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Figure 3. Tropomyosin and the actin filament. Skeletal muscle thin filament: A) only 
actin, B) with no Ca2+, C) with Ca2+, and D) decorated with myosin S1. The light green 
areas are weak myosin binding sites, the red areas are strong myosin binding sites, and 
the dark filament parallel to the gray actin strand is the Tm. Originally from [Gordon et 
al.,  2001].  
 
In Figure 3B there is no Ca2+ able to bind Tn and thus Tm remains and prevents 
access to the myosin binding sites, but with a high Ca2+ state [Fig 3C] Tm moves away 
from actin’s myosin binding sites. Decoration with myosin S1 [Fig 3D] however, 
demonstrates that with the binding of myosin S1 heads that there is an even greater 
movement of Tm farther away from the myosin binding sites. This implies a 3 state 
model that suggests Tm position is modulated by Tn, Ca2+ binding, as well as myosin 
binding. A blocked state in which there is low [Ca2+] and myosin cannot bind, but upon 
Ca2+ binding TnC the Tm is no longer strongly held blocking myosin binding sites (called 
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the closed state) and so a myosin head is able to bind. Once in the closed state and a 
myosin head is able to bind, it prevents the Tm from blocking adjacent sites, which 
allows more myosin to bind and propagate this open state across the filament. Proper 
Ca2+ dependent regulation is necessary for normal contraction of both skeletal and 
cardiac muscle. This is especially crucial in the heart where efficient pumping of the 
blood requires the careful coordination of systole (ventricular contraction/ejection) and 
diastole (relaxation/filling).  
During acute myocardial ischemia there are a host of intracellular changes 
including the accumulation of H+ that affect the contractile process. Myocardial ischemia 
is a partial or complete reduction of blood flow to cardiac muscle tissues, which deprives 
the muscle cells of the substrates necessary for energy production but also causes the 
build-up of cellular metabolites [Allen and Orchard,  1987]. During ischemia, ATP 
production through oxidative phosphorylation stops, causing a build-up of phosphate 
products (metabolites), which can lead to arrhythmias and a decrease in tension 
production [Allen and Orchard,  1987]. This can only be remedied if there is an increase 
of ATP generation by the re-initiation of oxidative phosphorylation or a decrease in ATP 
usage, although it is the H+ and Pi, not the reduced ATP that causes reduced contractility 
[Allen and Orchard,  1987].  
Myocardial ischemia for more than one hour can lead to permanent damage, but 
reperfusion, the restoration of blood flow to the tissues, can actually accelerate the 
damage [Allen and Orchard,  1987]. Reperfusion is not a perfect solution to ischemia, 
although if the tissue is reperfused before or during the early ischemic contracture then 
normal pressure is completely restored [Allen and Orchard,  1987]. However, if the tissue 
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is reperfused long after the ischemic contracture has occurred, then the pressure does not 
recover and can lead to cell damage advancement and the subsequent release of 
intracellular contents [Allen and Orchard,  1987]. This is deemed reperfusion damage, 
which occurs because Ca2+ is returned to the tissues after a period with low Ca2+ levels 
and this sudden accumulation can cause cellular damage.  
There are several theories as to the etiology of the reduced contractility from an 
ischemic attack, which range from issues with action potential generation, incorrect Ca2+ 
delivery to the contractile proteins, or some alteration and damage to the proteins 
themselves [Allen and Orchard,  1987]. Each is likely partially responsible for the 
reduced function. A covalent modification of Tn such as phosphorylation could lead to a 
loss of Ca2+ affinity or a competition between Ca2+ and other cations [Allen and Orchard,  
1987]. Porcine and murine (rats and mice) models of injury incurred from ischemia and 
reperfusion have displayed possible proteolytic cleavages (especially of TnI), 
phosphorylation of myosin and the regulatory proteins, and modifications due to reactive 
oxygen species [Rao et al.,  2007].  
Changes in Calcium Sensitivity and Tension 
Global ischemia occurs after sudden cardiac arrest, which causes a halt in 
myocardial contractions and thus blood circulation ceases as well. During this ischemic 
episode, there is reduced supply of necessary nutrients and an accumulation of harmful 
metabolites. The changes that occur can be severe and alter the myocardium’s ability to 
properly respond to Ca2+ [Fig 4]. In Figure 4C, the tracings were obtained from 
reperfused cardiac tissue that has undergone ischemia there is an increase in intracellular 
[Ca2+]. Figure 4D shows that force is reduced due a loss of Ca2+ sensitivity, which can be 
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seen as a rightwards shift in the force-pCa curve. Although there are differences between 
acidosis [Fig 4A  ,  Fig 4B] where there is no difference in intracellular Ca2+ and yet there 
is still a large loss in Ca2+ sensitivity and a reduction in force. Also in a failing heart [Fig 
4E  ,  Fig 4F] there is actually an increase in Ca2+ sensitivity, which results in a leftwards 
shift in the pCa curve. Not all conditions have the same impact on Ca2+ sensitivity, but 
each pathology causes detrimental effects on force production and alterations of the 
response to Ca2+. As cardiac contractions are precisely controlled events, any alteration to 
cardiac Ca2+ sensitivity could severely affect its ability to produce force.  
 
Figure 4. Changes in force-[Ca2+] relationships. A, C, and E are tracings of the force 
and cytosolic [Ca2+] in different physiological environments. B, D, and F are  the pCa-
force relationships. The effect of acidosis is shown in A and B, the effect of ischemia is 
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shown in C and D, and the effect of a failing heart is shown in E and F. Originally from 
[Day et al.,  2007].  
 
One research study applied a low flow ischemia model on porcine hearts, 
specifically fibers from the left ventricle supplied by the left anterior descending coronary 
artery, which can more effectively simulate ischemia in humans with coronary heart 
disease than other animal models. In this study the term “stunned” was used to refer to 
post-ischemic myocardium that had depressed contractile function, which could reverse 
over a few hours or days. This decreased function was hypothesized to occur because of 
decreased Ca2+ sensitivity and so the researchers directly tested if the myofilaments had 
reduced post ischemia Ca2+ sensitivity. Using an open-chest in vivo porcine heart model 
they obtained biopsies of myocardium before and after ischemia was induced and then 
subsequently permeabilized the fibers in order to measure Ca2+ and tension levels. This in 
vivo study allowed them to look at subsequent measurements of Ca2+ sensitivity and 
tension at different areas of the left ventricle and over the time span of the whole 
experiment. It was discovered that maximal Ca2+ activated tension generating ability after 
ischemia (2.77 ± 0.51  104 N/m2) did not differ much from the control (2.69 ± 0.27  104 
N/m2) [Hofmann et al.,  1993]. Also ischemia did appear to have induced a significant 
Ca2+ sensitivity reduction as the pCa required for half-maximal activation of tension 
decreased from 5.88 ± 0.05 control to 5.69 ± 0.03 post-ischemia [Hofmann et al.,  1993]. 
This decreased sensitivity likely caused reduced velocity and reduced tension generating 
ability at low Ca2+ concentration levels.  
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Oxidative Damage 
There has also been evidence of an increase in nitric oxide, superoxide, 
peroxynitrite (ONOO-), and hydroxyl radicals that can cause damage to cells and 
especially to the muscle proteins themselves [Rao et al.,  2007]. Some of the damage can 
be prevented by reducing the toxicity of the radicals or removing the damaged proteins, 
although the cell cannot always degrade the damaged proteins and thus their altered or 
loss of function remains part of the system [Dean et al.,  1997]. When the proteins are 
oxidized it often leads to a loss of function or unfolding, which in turn can allow for more 
accessibility to proteases [Dean et al.,  1997]. Reactive oxygen species (ROS) can 
damage macromolecules in many cell types and play key roles in many diseases such as 
ischemia. During ischemia there can be an increase in the levels of these damaging 
compounds. One such compound called (ONOO-) has been shown to cause protein 
modifications and has reduced maximum isometric tension at high concentrations 
[Alvarez and Radi,  2003]. It is formed when nitric oxide and superoxide radicals react 
and this ONOO- product can permeate biological membranes and act as both a nitrating 
agent and an oxidizer [Alvarez and Radi,  2003]. ONOO- can directly interact with amino 
acid residues and even produce more free radicals that can continue to cause more protein 
alterations. Primarily residues containing sulfur (Cys, Met) or aromatic groups (Trp, Tyr, 
Phe, His) are the first to react with these free radicals [Alvarez and Radi,  2003]. Another 
study showed that there were velocity reductions for myosin treated with ONOO- and 
that this may cause modifications to myosin binding protein-C instead of myosin itself at 
10uM [ONOO-] [Snook et al.,  2007]. There were also some functional losses due to 
actin nitration as well, although bare actin suffered a larger dysfunction compared to 
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regulated actin at 10uM and 100uM [ONOO-] [Snook et al.,  2007]. This may have been 
due to Tm and Tn subunits interfering with ONOO- access to key sites, which was 
supported from data displaying that the two proteins showed no nitration at 10uM and 
only a slight amount at 100 uM [Snook et al.,  2007].  
Other damaging compounds such as superoxide and nitric oxide could increase in 
prevalence and lead to damage during myocardial ischemia and reperfusion in a murine 
model [Liu et al.,  1997]. It was discovered that superoxide in tissues of the ischemic 
cardiac muscle region were increased by 140%, and nitric oxide levels increased by 90%, 
and nitric oxide synthase activity was increase by 212%, while the non-ischemic regions 
were unchanged [Liu et al.,  1997]. This data displayed that nitric oxide and superoxide 
formation were increased after reperfusion of ischemic heart tissue and that they may be 
implicated in reperfusion injury.  
 Nitric oxide production increases during early reperfusion and can react with 
superoxide to form the damaging ONOO-, which can lead to protein alterations and a 
reduction in function. It has also been seen that adding superoxide dismutase or halting 
nitric oxide synthase activity eliminated the nitric oxide increase [Zweier et al.,  2001]. 
Also there was an over two fold recovery of contractile function in hearts treated with 
inhibitors of superoxide dismutase or nitric oxide synthase, which displays possible 
techniques to reduce these oxidative species [Zweier et al.,  2001]. After myocardial 
infarction and heart failure nitric oxide synthase is expressed and the more nitric oxide 
produced lead to more cardiac dysfunction [Feng et al.,  2001]. After myocardial 
infarction in mutant mice with knockout nitric oxide synthase expression there were a 
lower mortality rate and improved contractility [Feng et al.,  2001]. Nitric oxide produced 
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by endothelial nitric oxide synthase-3 however has been shown to limit the damage from 
ischemia-reperfusion and it has been shown that overexpression of this gene specifically 
in cardiomyocytes improved cardiac function [Elrod et al.,  2006]  
 Free radicals can damage cellular macromolecules by highly reactive chain 
reactions that involve reactive compounds removing electrons form other molecules and 
thus creating more reactive substances [Dean et al.,  1997]. In reperfused rabbit hearts 
there were increases of semiquinone, reactive oxygen species, a nitrogenated radical, and 
hydroxyl radicals that can all be generated in post-ischemic cardiac muscle and could 
cause damage [Zweier et al.,  1989]. Superoxide dismutase, deferoxamine, and mannitol 
were able to reduce the increase of the reactive oxygen species and thus could also be 
reasonable strategies to decrease the oxidative damage that can occur [Zweier et al.,  
1989]. After ischemia the subsequent reperfusion causes a large release of free oxygen 
radicals and expression or addition of superoxide dismutase immediately before 
reperfusion reduces the levels to closer to non-reperfused [Grill et al.,  1992]. Another 
avenue of protection against ischemia-reperfusion damage is the MCP-1 (monocyte 
chemoattractant protein-1), which was expressed in transgenic mice after global 
ischemia-reperfusion and lead to protection against reactive oxygen species induced 
cardiac dysfunction [Morimoto et al.,  2008]. In vitro experiments showed that ischemia-
reperfusion caused an increase in MCP-1 mRNA expression [Morimoto et al.,  2008]. 
Mice with cardiomyocyte specific MCP-1 overexpression stopped superoxide formation 
during ischemia-reperfusion and there was higher superoxide dismutase activity in the 
transgenic mice than wild type [Morimoto et al.,  2008]. These oxidative species can 
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cause damage such as nitrosylations, which can be detected by specific gels (S-
nitrosylated protein detection kit, Cayman Chemical Company, Ann Arbor, Michigan).  
Possible Myosin Alterations 
It is known that phosphorylation can play a role in regulating myosin activity, 
which leads to reason that changes in phosphorylation can alter contractile function 
[Alamo et al.,  2008]. The phosphorylation of the regulatory light chains can interact 
within the same S1 head or between the 2 myosin heads as well [Alamo et al.,  2008]. 
This phosphorylation of the regulatory light chain may reduce the interactions between 
the 2 myosin heads, thus allowing myosin to interact with actin and produce contractile 
force [Alamo et al.,  2008].  
One study discovered that in human heart failure due to mitral regurgitation that 
there was no change to the actomyosin ATPase activity, contrary to evidence found in 
some animal studies [Nguyen et al.,  1996]. Tissue samples were obtained from the 
anterior segment of the left ventricular subepicardial wall of the hearts and the isolated 
myosin was analyzed with in vitro motility assays [Nguyen et al.,  1996]. The mean 
velocity of the normal left ventricle function tissue was 1.3 ± 0.3 um/s and in the mitral 
regurgitation heart failure it was 1.0 ± 0.3 um/s, which was not a significant difference 
[Nguyen et al.,  1996]. One can infer that the myosin did not have mechanical or ATPase 
activity changes from mitral regurgitation heart failure in terms the motion producing 
capacity, but this does not prove that there were no physical modifications [Nguyen et al.,  
1996].  
If cardiomyocytes are pharmacologically preconditioned (with adenosine) in vivo 
to protect against further ischemic events there is an increase in phosphorylation of 2 sites 
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to myosin light chain 1 (MLC-1) [Arrell et al.,  2001]. This suggests the phosphorylation 
of MLC-1 could be part of the molecular changes of preconditioning that can prevent 
some of the damage from ischemia. Although there is evidence that ischemia itself does 
not cause a change in phosphorylation. It has been displayed that in perfused heart fibers 
there was 86.6 ± 2.5% unphosphorylated MLC-1 and ischemic fibers with 86.5 ± 2.9% 
unphosphorylated MLC-1 [Han and Ogut,  2010]. As well as 76.3 ± 2.8% 
unphosphorylated Myosin Light Chain-2 (MLC-2) in perfused fibers and 73.1 ± 2.7% 
unphosphorylated MLC-2 in ischemic fibers [Han and Ogut,  2010]. Their data showed 
no significant changes in light chain phosphorylation status in perfused and ischemic rat 
cardiac muscle fibers, which helped focus attention on the other sections of myosin that 
may actually be modified.  
Areas of mouse heart that were not part of the myocardial infarction site could 
have protein modifications as well. These remote areas are part of the overall left 
ventricular dysfunction, or decreased contractile function, brought on by localized 
myocardial infarction. One study found the function of infracted heart myosin was 
reduced 0.56 ± 0.11% (adjacent) and 0.60 ± 0.16% (remote) of the control [Rao et al.,  
2007]. There was also only 85% of control velocity (control was 4.9 ± 0.2 um/s) in the 
adjacent zone for moving filaments in vitro as well as a decrease in the number of actin 
filaments bound to the motility surface, which was likely due to impaired actin-myosin 
binding [Rao et al.,  2007]. This study isolated identical myosin concentrations 
(250ug/mL) from each muscle tissue area sampled to ensure that the number of myosin 
on the in vitro surface was not the reason for the decreased function and velocities found 
in both the adjacent and remote areas [Rao et al.,  2007].  
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Myosin was analyzed by SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel 
electrophoresis) and stained with 5-IAF (a fluorescent dye) showed that there was a 25 ± 
1% decrease in reactive cysteine-sulfhydryls in the remote zone compared to the control, 
which meant that some available reactive cysteines were oxidized [Rao et al.,  2007]. 
Alterations to one of these reactive cysteines could possibly have led to unfolding of the 
protein and thus a loss of function. Also SDS-PAGE showed no cardiac myosin isoform 
changes [Rao et al.,  2007]. This experiment allowed one to theorize that left ventricular 
dysfunction in the remote area after a myocardial infarction may be due to some type of 
modification to myosin. The myosin dysfunction may have been caused by oxidative 
stresses that lead to modifications of the heavy chain or myosin binding protein-C [Rao et 
al.,  2007]. Another study displayed that ONOO- inhibited the S1 actin activated ATPase 
rate up to 50% and that ONOO- likely oxidized the reactive cysteines (C707 and C697) 
on Myosin S1 fragment, which could also cause the protein to partially unfold and thus 
increase access for protease degradation [Tiago et al.,  2006]. This degradation could be 
due to the activity of matrix metalloproteinase-2, which normally acts outside the cell, 
but has been shown to cleave MLC-1 and result in altered cardiac function in vitro 
[Sawicki et al.,  2005]. Inhibiting matrix metalloproteinase-2 reduced cleavage of 
proteins from IR (specifically MLC-1 was identified by mass spectrometry). MLC-1 can 
be another target for matrix metalloproteinase-2 and this cleavage may lead to the 
reduced cardiac function post IR [Sawicki et al.,  2005].  
Possible Troponin Alterations 
 Alterations to Tn are one of the most likely reasons for the decreased contractile 
function post-ischemia. In an in vivo permeabilized fiber study of rat cardiac muscle, 
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specifically the anterolateral papillary, it has been shown that there are changes in 
phosphorylation of two subunits of Tn (TnI and TnT) [Han and Ogut,  2010]. A ligature 
was secured on one of the left coronary arteries, which restricted the blood flow for 30 
minutes (ischemia), and then it was removed to allow reperfusion for 60 minutes. 
Ischemia and reperfusion treatment resulted in reduced force and Ca2+ sensitivity 
accompanying a loss of maximal force, an increased Ca2+ EC50 (Ca2+ concentration 
needed to achieve the half maximal force), and a clear reduction in stiffness [Han and 
Ogut,  2010]. A 2-dimensional SDS-PAGE was used to determine if TnT was either 
mono or bis-phosphorylated. It was discovered that perfused cardiac tissue contained 
22.1 ± 2.2% mono-phosphorylated and 77.6 ± 2.3% bis-phosphorylated TnT [Han and 
Ogut,  2010]. In ischemic fibers there was an increase of mono-phosphorylated-TnT to 
39.6 ± 3.0% and a decrease of bis-phosphorylated-TnT to 60.3±2.9% [Han and Ogut,  
2010]. Also the phosphorylation of Ser23/24 on TnI of perfused cardiac muscle was 
discovered to be 100 ± 7.4% and this decreased to 65.9 ± 16.2% in ischemic fibers [Han 
and Ogut,  2010]. This suggests that myosin is unlikely to be the cause for decreased 
cardiac muscle function, but the thin filament regulation is very likely to have several 
modifications that can result in altered function [Han and Ogut,  2010]. The reduced 
initial attachment rate found in the ischemic tissue displayed that the Ca2+ controlled thin 
filament activation was likely the causal element [Han and Ogut,  2010]. The TnT 
dephosphorylation could somehow influence the status of the thin filament and thus alter 
the transition of crossbridges to and from attachment states. This data clearly implicates 
TnT and TnI modification in controlling contractile capabilities.  
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Isolated Tn from end-stage failing and non-failing human hearts have also been 
used in the regulated in vitro motility assay and functional changes occurred. Tn from 
non-failing cardiac tissue at pCa5.4 displayed increases in thin filament (actin-Tm) 
velocity after addition of Tn from both failing- and non-failing human hearts, however 
the magnitude of velocity change was significantly larger with the non-failing heart Tn 
(52 ± 4% ) than the failing-heart Tn (35 ± 2%) [Knott et al.,  2002]. There was an 
increased sensitivity to Ca2+ for the failing heart Tn as the EC50 for failing heart 
decreased 1.76 ± 0.20 fold as compared to non-failing cardiac Tn and filament velocity 
was also found to have decreased 1.89 ± 0.62 fold in the failing heart tissue [Knott et al.,  
2002]. This data demonstrated that a functional alteration to Tn could affect Ca2+ 
sensitivity and contractile function of cardiac myofibrils.  
In another study, low blood flow ischemia was performed for 3 days to the left 
anterior descending artery in a murine model. Using phospho-specific antibodies it was 
discovered that there may have been Ser23/24 and Ser43/45 phosphorylation changes on 
TnI [Christopher et al.,  2009]. This reduction of Ser23/24 phosphorylation on TnI had 
been seen in other studies as well [Han and Ogut,  2010]. Additionally affinity 
chromatography displayed that TnI had reduced affinity for TnC, which increased the 
likelihood that modifications of TnI can contribute to reduced contractile function 
[Christopher et al.,  2009].  
There are 2 isoforms of TnI in humans and there is a transition from ssTnI (slow 
skeletal) expressed only in embryonic and neonatal hearts and cTnI (cardiac), which 
replaces the embryonic isoform over time [Day et al.,  2007]. They are 70% homologous, 
but cTnI has a 32 amino acid sequence that can be targeted for phosphorylation by cAMP 
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dependent protein kinase A and this phosphorylation site can lead to decreased Ca2+ 
sensitivity and cardiac myocyte relaxation [Day et al.,  2007]. Also there has been a lot of 
research displaying that TnI is cleaved by Ca2+ activated calpain (a proteolytic enzyme) 
and can result in the decreased myofilament function [Day et al.,  2007].  
In addition, it has been shown that in an expressed truncated 1-192 cTnI mutant 
there is an approximately 9o shift towards the inner groove of the actin filament when 
activated with Ca2+ alone [Galinska et al.,  2010]. This shift in equilibrium (28 to 57% 
enhanced C state) towards the open state would suggest that upon cleavage of the last 17 
residues of cTnI there is an “enhanced C-state” that can increase the chance for myosin to 
bind and thus allow for earlier activation of the filament (less Ca2+ needed i.e. increased 
Ca2+ sensitivity) [Galinska et al.,  2010]. Although this suggests that there is only a 
difference when Ca2+ is bound as the frequency of the Tm occurring in the blocked state 
remained virtually identical.  
Possible Tropomyosin Alterations 
Tm can be phosphorylated, which can affect the way the thin filament is regulated 
and thus affect contractility. There can be a significant change in the phosphorylation 
level in muscle tissue isolated from the area completely remote from a site of localized 
infarction and the phosphorylation of Tm may be caused by oxidative stress from the 
ischemic area [Rao et al.,  2007]. Another experiment, which involved rabbit fast skeletal 
leg muscles, displayed phosphorylation of alpha-alpha-Tropomyosin (αα-Tm) and TnT 
[Heeley,  1994]. The five parts of striated muscle thin filaments (actin, Tm, TnT, TnC, 
TnI) allow for Ca2+ controlled contraction activity and TnT actually binds to Tm at two 
different sites. Different combinations of isomorphs of Tm and TnT can have different 
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Ca2+dependent tension levels [Heeley,  1994]. The phosphorylation of Ser283 at site one 
of Tm and phosphorylation of acetyl-Ser 1 of TnT can change Ca2+ related tension and so 
the purpose of the study was to display the effects of in vivo modification on thin filament 
function [Heeley,  1994]. Using fully phosphorylated αα-Tm, TnT, and T1 (T1 is a 
fragment of TnT), it was discovered that phosphorylated Tm increased the activating 
properties of the regulatory thin filaments [Heeley,  1994].  
Fragment T1 had equal affinity to αα-Tm whether the Tm was phosphorylated or 
not, but the TnT and phosphorylated αα-Tm affinity was stronger than the control 
[Heeley,  1994]. With non-phosphorylated αα-Tm, T1 down regulated actin-activated 
myosin-S1 ATPase activity and this displayed that T1 of the TnT protein has modulating 
effects on this ATPase activity, although TnI bound to Tm had a more significant 
reduction in ATPase activity and thus was likely a more important factor [Heeley,  1994]. 
Activation of myosin-S1 was twice as fast for phosphorylated αα-Tm regulated filaments 
and yet there was never a significant effect from phosphate on acetyl serine 1 of TnT (or 
fragment T1), which suggests that higher levels of phosphorylated Tm may actually be 
able to produce more rapid contractions [Heeley,  1994].  
Quantifying Post-Translational Modifications with Mass Spectrometry 
High pressure liquid chromatography coupled with electrospray ionization tandem 
mass spectrometry can determine the levels of post-translational modifications in protein 
samples such as native thin filaments (NTF) [Previs et al.,  2008]. Liquid chromatography 
involves the separation of molecules via passing a sample in solution through a column 
that has different affinities for certain functional groups or other characteristics of the 
molecules. For our study we used hydrophobic interaction chromatography (HIC) and 
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thus we used a column (C18) designed to interact with the hydrophobic residues in our 
sample peptides [Weith et al.,  2012]. During chromatography, a column is loaded with 
the sample and then the solution is slowly changed over a gradient to allow proteins to be 
separated slowly over time, which allows an undesired "void" volume to be washed out 
of the column before the sample peptide.  
During electrospray ionization, a high voltage current is applied to samples to 
vaporize them into ions, which can then be separated by their mass-to-charge ratio via the 
electromagnetic fields within the mass spectrometer. These ions can be quantified and the 
ion profiles compared to a library of known protein products. The amount of 
phosphorylation can be determined by comparing the ion currents from each desired 
peptide sequence in a phosphorylated set to its dephosphorylated reference peptide using 
a mass balance approach [Previs et al.,  2008  ,  Weith et al.,  2012]. Two sets, one with 
and one without dephosphorylation by alkaline phosphatase, are required to quantify a 
change to the peptides phosphorylation status. This is due to phosphorylation causing 
mis-cleavage when near tryptic cleavage sites [Steen et al.,  2005], which otherwise 
would alter the results from the mass spectrometry.  
Summary 
Ischemia has been proven to induce a clear decrease in tension related to 
decreased Ca2+ sensitivity, which implicates alterations to the cardiac regulatory proteins 
as well as the myosin in terms of their interactions with actin. There are several damaging 
compounds which can accumulate during periods of restricted blood flow and might 
cause deleterious modifications to the regulatory proteins and possibly myosin as well. 
For example myosin was found to have some reactive cysteines oxidized due to ischemia 
 23 
 
and any alterations to these areas could lead to a loss of function, but there are conflicting 
data as to whether myosin is a primary cause of decreased function. Myosin binding 
protein -C was also implicated, because it had an increase in carbonylation due to 
oxidative stress in the tissues remote to localized heart tissue infarct correlated with 
decreased function. Changes in phosphorylation status of TnI could be a key factor in 
Ca2+ controlled actomyosin interaction, because of its interaction with TnC (the subunit 
that binds Ca2+). Also Tm, from skeletal muscle, was found to have an increase in 
phosphorylation, but dissimilar to Tn phosphorylation it produced more rapid 
contractions.  
 Although there has been extensive research attempting to elucidate the factors that 
cause changes in tension and contractile properties of post-ischemic cardiac tissue, there 
is still no specific understanding of the direct mechanism of this change. There are many 
leading theories involving oxidative damage or metabolite build up that could lead to 
covalent modifications to regulatory proteins or to myosin itself and thus reduce force 
production. The specific mechanism causing reduced Ca2+ sensitivity remains unknown, 
but it may be that the Ca2+ binding subunit TnC loses affinity for Ca2+ upon direct 
phosphorylation or phosphorylation of another subunit. Differences in animal models can 
be especially important and thus porcine post-ischemic and reperfusion models should be 
studied to understand tissues very similar to humans. One of the most important tools to 
employ in these studies is the use of in vitro motility assays specifically designed to 
examine the differences in post-ischemic and reperfused myosin and NTF (actin, Tn, and 
Tm). The actual change to the actomyosin crossbridge cycle is also unknown and without 
knowledge of the affected proteins it is difficult to pinpoint the specific alterations in the 
 24 
 
cycle. Mass spectrometry can accurately detect the post translational modifications to the 
proteins and thus can suggest underlying mechanisms for observed functional changes. It 
remains unanswered if there is permanent ischemia and reperfusion damage or if there 
are therapies that can reverse the changes which occurred to the protein structures. 
Research needs to be conducted to discover the protein alterations and thus the 
mechanisms by which reduced left ventricle function occurs before more effective 
treatments can be discovered.  
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CHAPTER III 
METHODS 
Ischemia/reperfusion protocol 
All surgical procedures involving animals were in strict compliance with the NIH 
Guide for the Care and Use of Animals. The parent study from which the tissue samples 
were obtained was IACUC-approved and conducted in a USDA certified laboratory. 
Female domestic Yorkshire swine aged 3–4 months and weighing approximately 30–35 
kg prepared as previously described [Mader et al.,  2010], were used for the cardiac 
arrest-resuscitation experiments. The three animals included in this substudy were part of 
a larger study involving 80 animals, 45% of which attained ROSC. During the protocol 
the animals were sedated with intramuscular telazol (5 mg/kg), ketamine (2.5 mg/kg), 
and xylazine (2.5 mg/kg). Isoflurane was provided to facilitate endotracheal intubation 
and intravenous (IV) access. The inhalation anesthetic was then discontinued and a 
surgical plane of anesthesia was achieved using an IV propofol bolus (2 mg/kg) followed 
by a continuous infusion (80 mcg/kg/min) titrated to effect. The animals were ventilated 
with room air, using a volume-cycled ventilator adjusted the tidal volume and ventilatory 
rate to maintain eucapnea. A nasopharyngeal probe was placed through the oral cavity 
into the animal's esophagus to measure core body temperature. Three surface electrodes 
configured to correspond to a standard lead II electrocardiogram (ECG) surface 
electrodes were secured to the proximal forelimbs and thorax. 
Neuromuscular paralysis was induced with pancuronium (4 mg initial bolus IV) 
and an arterial introducer (8.5 Fr) was placed into the right femoral artery and a venous 
introducer (8.5 Fr) into the right femoral vein under direct visualization. Micro–
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manometer tipped pressure catheters (Mikro-Tip, Millar Instruments, Houston, TX) were 
placed into the ascending aorta and right atrium. Arterial blood gas was obtained as soon 
as access was established and just prior to ventricular fibrillation induction. All central 
vascular access ports were connected to a pressurized liter bag of normal saline 
containing heparin. The ECG tracing, as well as the arterial and venous pressures were 
monitored and recorded continuously throughout the experiment (PowerLab M8/30, AD 
Instruments, Colorado Springs, CO). Immediately before induction of ventricular 
fibrillation, a 2-mg bolus of pancuronium was given, the propofol infusion was 
discontinued, and the ventilator was disconnected. 
 
 
 
Figure 5. Global ischemia protocol. Ventricular fibrillation was induced as previously 
described [Mader et al.,  2010] with a transthoracic current (100mA at 60Hz) and was 
untreated for 12min. ventricular fibrillation lasted for 4min before complete electrical 
failure was reached (green bar) at which point circulation stopped completely (yellow 
bar) and finally metabolic failure was reached at ~10min. (pink bar). Resuscitation efforts 
began 12min after induction of ventricular fibrillation, initially with manual chest 
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compressions (MCC) and infusion of epinephrine (drug, 0.1mg/kg). At minute 15 we 
attempted to restart circulation electrically (RS1) and at 18min. If ROSC it was 
maintained for 2hrs and then the animals were sacrificed and cardiac muscle samples 
were taken from the left ventricle (IR2). If ROSC was not restored then after 20min 
cardiac muscle samples were taken from the LV (IDNR). Control animals were prepared 
identically but did not receive the ischemia protocol (Control). “ˆ” Indicates when a drug 
was administered. 
 
 
Global ischemia and the resuscitation protocol were performed as previously 
described [Mader et al.,  2010]. Briefly, ventricular fibrillation was induced by a 3-s, 60-
Hz, 100-mA transthoracic alternating current. At minute 12 of untreated ventricular 
fibrillation, dynamic baseline characteristics were again recorded and resuscitation was 
attempted beginning with mechanical chest compressions using an oxygen-powered 
mechanical resuscitation device (Life-Stat Mechanical CPR System, Michigan 
Instruments, Grand Rapids, MI) that provides standardized closed chest compressions in 
the anterior-posterior direction at a rate of 100/min. The device was programmed to 
deliver chest compressions and ventilation (Vt = 500 cc, Fi02 = 100%) in a ratio of 30:2. 
The animals were resuscitated using a standard combination of resuscitation drugs 
[Fig 5]. Attempted resuscitation was terminated after the ROSC or 20 min of failure. 
Animals attaining ROSC were immediately placed back on the ventilator, a low dose 
propofol infusion was restarted and titrated to optimize the effect, and norepinephrine 
was given intravenously to maintain a systolic blood pressure above 80 mm Hg for 2 h. 
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At the conclusion of each experiment, the hearts were immediately excised, diced, and 
put into liquid nitrogen. The samples were kept on dry ice during transport and stored in a 
−80°C freezer.  
Cardiac tissue samples were obtained from porcine hearts that underwent one of 
three conditions: (1) samples from a control animal that was subjected to the surgery but 
that did not experience cardiac arrest or subsequent resuscitation and reperfusion 
(control); (2) from an animal subjected to 12 min of global ischemia and attempted 
resuscitation for 20 min that included epinephrine (0.01 mg/kg), vasopressin (0.5 U/kg), 
amiodarone (4 mg/kg), sodium bicarbonate (1.0 mEq/kg), and metoprolol (0.2 mg/kg) but 
spontaneous circulation failed to return (IDNR); and (3) from an animal that underwent 
12 min of global ischemia and successful resuscitation after epinephrine (0.01 mg/kg), 
vasopressin (0.5 U/kg), amiodarone (4 mg/kg) on the third defibrillation attempt, 
followed by 2 h of sustained reperfusion (IR2). 
Proteins 
Cardiac myosin was isolated from porcine ventricular tissue based on a method 
previously established for mouse cardiac tissue [Tyska et al.,  2000]. The purification of 
the myosin molecules involves the manipulation of salt concentration of the extraction 
solution, which at low salt the myosin monomers form filaments that can allow them to 
be isolated from the other tissue proteins by ultracentrifugation. Briefly a 2-mL aliquot of 
extraction buffer (300 mM KCl, 150 mM PO4, 20 mM EDTA, 5 mM MgCl2, pH 6.7, 3.3 
mM ATP, and 5 mM DTT) was added to ~400 mg of porcine cardiac tissue and 
continuously homogenized for 12 minutes in a 2mL dounce homogenizer. The dounce 
was chilled prior to introduction of the tissue as well as kept submerged in ice for the 
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majority of the 12 minutes of homogenizing. The solution was then centrifuged (5 
minutes; 10,000 g; 4 °C) to pellet insoluble tissue and the supernatant was centrifuged 
once more for 20 minutes at 400,000 g to remove any filamentous proteins. The myosin 
containing supernatant was then precipitated by 10-fold dilution with ddH2O for 60 
minutes and then centrifuged for 10 minutes at 10,000 g, and 4 oC. The supernatant was 
discarded and the myosin pellet was gently rinsed with cold ddH2O. The pellet was 
homogenized in a minimum volume of a high salt buffer (25 mM Imidazole, 600 mM 
KCl, 1 mM EGTA, 4 mM MgCl2, pH 7.4) and the concentration determined with a 
spectrophotometer (extinction coefficient of 0.55, [Margossian and Lowey,  1982]).  
An additional purification was performed on a subset of the cardiac myosin using 
HIC as previously described [Malmqvist et al.,  2004] with minor modifications. Briefly, 
the isolated myosin was first dialyzed overnight at 4 °C against 1.45 M ammonium 
sulfate (AmSO4) and then centrifuged (15 minutes; 10,000 g) to remove any aggregating 
proteins. The supernatant was loaded on to the HIC column (5 mL Toyo pearl ether-
650M, Tosoh Biosciences Inc., Grove City, OH) at 1.45 M AmSO4. The AmSO4 was 
reduced to 1.2 M causing the elution of the purified myosin, following a collection of 
proteins that weakly interacted with the column (Figure 7 shows chromatograph and gel).  
NTF were isolated using an established protocol [Lehman et al.,  1995], in which 
~200 mg of tissue was exposed to thin filament extraction buffer (25 mM imidazole, 1 
mM EGTA, 100 mM KCl, 4 mM MgCl2, 5 mM ATP, 10 mM DTT, pH 7.0) and 
homogenized for 12 min on ice (0°C). The homogenate was initially centrifuged (10,000 
g, 4°C) for 5 min followed by a second centrifugation (40,000 g, 4°C) of the supernatant 
for 20 min to remove myosin and any bulk tissue. Subsequently, the supernatant was kept 
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and centrifuged (200,000 g, 4°C) again for 45 min to pellet the thin filaments which were 
re-suspended in 300 μL of thin filament extraction buffer before a final clarification spin 
(40,000 g, 4°C) for 5 min to remove any remaining myosin. The supernatant was kept 
and then a final centrifugation was performed for 45 min at 200,000 g to collect the thin 
filaments. The resultant pellets were brought up in an extraction buffer (7.0 pH, 25 mM 
imidazole, 1 mM EGTA, 100 mM KCl, 4 mM MgCl2, 10 mM DTT) labeled 
tetramethylrhodamine isothiocyanate-phallodin (TRITC-phallodin) (Sigma-Aldrich Inc., 
St. Louis, MI) at a 1 μM. Chicken skeletal actin was also used to assess the cardiac 
myosin function and it was isolated from pectoralis muscle and fluorescently labeled with 
TRITC-phallodin. 
Solutions 
The pH of each buffer was determined by a Fisher Scientific pH-meter, which 
was calibrated prior to determining the pH of each solution. Sodium hydroxide (NaOH) 
was used to increase the pH of each motility solution and hydrochloric acid (HCl) was 
used to decrease it.  
Immediately prior to beginning a motility experiment, the myosin was further 
purified by removing myosin heads that were trapped in a rigor state and thus inactive. 
This involved the addition of filamentous chicken skeletal actin and 2mM ATP and 
centrifugation at 400,000g for 20 minutes at 4°C. After which the supernatant was 
introduced into the flow cells in the motility assay. The rigor-like myosin heads would 
remain bound to the filamentous actin in solution, but the functional myosin heads would 
hydrolyze the ATP, separate from the filamentous actin, and would remain in the 
supernatant solution.  
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In vitro motility 
Flow cells were used to inject different elements that were needed to simulate 
physiological environments and to study the motility of molecular motor proteins. This 
involves nitrocellulose coated coverslips glued onto a glass slide with enough space for 
the injection of solutions. The technique was created to view moving fluorescent actin 
filaments in the presence of ATP on a bed of myosin, which is affixed to glass [Kron and 
Spudich,  1986]. The flow cell temperature was maintained at 30o C with an objective 
temperature controller collar.  
The impact of the ischemia/reperfusion of contractile protein function was 
assessed using the in vitro motility assay using previously established methods [Debold et 
al.,  2011  ,  Debold et al.,  2012]. Briefly, 60uL of isolated myosin (in a high salt buffer: 
300 mM KCl, 25 mM Imidazole, 1 mM EGTA, 4 mM MgCl2, pH 7.4, 10 mM DTT) was 
adhered to a nitrocellulose coated microscope coverslip as part of a flow cell at 200ug/ml 
and incubated for 30 seconds. 60uL of bovine serum albumin (BSA) (0.5mg/mL) was 
then added to cover any areas of the surface not coated by myosin and allowed to 
incubate for 60 seconds. Then 60uL of actin coat (actin that had been put onto a vortex 
mixer to ensure only small actin filaments would be present for the myosin heads to bind 
to) in the absence of ATP, was injected into the flow cell and incubated for 30 seconds. 
40uL of ATP wash was injected into the flow cell and then incubated for 30 seconds, 
which was repeated immediately after the initial incubation for a total of 80uL. This 
allowed all functional myosin heads to release the small actin coat pieces. 40uL of 
TRITC-labeled NTF (5nM in actin buffer) was then injected and incubated for 60 
seconds, which was repeated immediately after the initial incubation for a total of 80uL. 
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Then 60uL of actin buffer was flowed through the cells, which maintained a low salt 
environment for the actin. 60uL of the final motility buffer was added to the chamber (25 
mM KCl, 25 mM Imidazole, 1 mM EGTA, 4 mM MgCl2, pH 7.4, 2 mM ATP, 10 mM 
DTT, with an amount of CaCl2 required to achieve the appropriate free [Ca2+]), which 
also contained an oxygen scavenging system (glucose, glucose oxidase, and catalase) to 
slow photo-bleaching of the fluorescently labeled actin filaments.  
The flow cells were then loaded onto a Nikon Eclipse Ti inverted microscope 
with a 100X, 1.4NA CFI Plan Apo objective and the fluorescent actin filaments were 
visualized by an ICCD camera (Stanford Photonics, Inc., Palo Alto, CA). The video was 
captured by an Epix-LVDS frame grabber (Epix, Inc., Buffalo Grove, IL) coupled to the 
ICCD camera. Piper ControlTM 2.5 software (Stanford Photonics, Inc. Palo Alto, CA) was 
used to capture three to four video fields for each flow cell at 10 frames s-1 for 30 
seconds. The filament motions were manually tracked using the MtrackJ [Meijering et 
al.,  2012] plugin for ImageJ [Abramoff et al.,  2004]. The percentages of filaments 
moving were calculated via an ImageJ plug-in called wrMTrck [Nussbaum-Krammer et 
al.,  2015]. 4-5 motility experiments were conducted each using fresh isolations for both 
myosin and thin filaments for each condition.  
Differences in naked skeletal actin and NTF velocities among each condition 
were determined using a One-Way ANOVA followed by a Tukey’s HSD post hoc. To 
determine the Ca2+ sensitivity of the NTF, their velocities as a function of the –log of the 
Ca2+ concentration (pCa) were fitted to the Hill equation: 
V = Vmax/(1 + 10
n(pCa50 –pCa)) 
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using SigmaPlot R 11.2 (Systat Software, San Jose, CA). The hill equation derived the 
Ca2+ concentration required to elicit half maximal filament velocity (pCa50) and the Hill 
coefficient (n) to gain insight into the cooperative behavior of activation.  
Mass Spectrometry  
In preparation for mass spectrometry denaturing SDS-PAGE was conducted with 
precast 12% bis-Tris polyacrylimide gels (BioRad, Life Science Research, Hercules, 
CA). The identified bands were excised from the gel, cut into small cubes, and placed 
into Eppendorf tubes. Residual stain and excess water was removed with a 50% 
acetonitrile solution and the gel slices were dried in a speed vacuum device as previously 
described [Previs et al.,  2012]. Next, one set of samples was rehydrated with 8 μL of 
alkaline phosphatase (Sigma–Aldrich Inc., St. Louis, MI) in 92 μL of ammonium 
bicarbonate and incubated for 18 h at 30°C, allowing the phosphatase to thoroughly 
impregnate the gel and dephosphorylate the protein samples. The samples were dried via 
a speed vacuum device and subsequently rehydrated with 2 μg of trypsin (Promega, 
Madison, WI) in 100 μL of ammonium bicarbonate and incubated for 18 h at 37°C. After 
18 h of incubation 7 μL of 90% formic acid was added to deactivate the trypsin. The 
resultant peptides were extracted with 25 mM ammonium bicarbonate/50% acetonitrile 
solution, dried in a speed vacuum device, and reconstituted in 0.05% heptafluorobutyric 
acid.  
Electrospray ionization liquid chromatography tandem mass spectrometry (LC-
MS) was carried out in data dependent mass spectrometry mode using an LTQ ion trap 
mass spectrometer (Thermo Electron Corporation) coupled to a 1 mm C18 column as 
previously described [Weith et al.,  2012]. Initial SEQUEST searches were performed to 
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identify peptides using the IPI human protein sequence database (v3.75) downloaded 
from the EMBL- EBI website. Subsequent searches only contained the pig cardiac TnI 
(A5X497) and pig α-Tm (P42639) sequences downloaded from UniProtKB. The degrees 
of site-specific TnI and α-Tm phosphorylation and truncation of the C-terminus of TnI 
were determined from the extracted ion currents for specific peptides of interest in the LC 
chromatograms using label free-proteomic strategies as described in the Results Section. 
Phosphorylation levels were determined using each of the five reference peptides listed 
for TnI and α-Tm in the Results Section in three samples from each group, before and 
after treatment with alkaline phosphatase. Statistical significance was determined from 
the individual measurements from each reference peptide using a Student's t-test.  
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CHAPTER IV 
RESULTS 
Changes to Contractile Protein Function 
Cardiac myosin’s ability to translocate actin filaments in vitro was not 
significantly different in samples that underwent either ischemia with (IR2) or without 
reperfusion due to failed resuscitation (IDNR) [Fig 6]. This indicated that the 
ischemia/reperfusion protocol may not have had an effect on the myosin’s function.   
 
 
Figure 6. Effect of ischemia/reperfusion on Vactin. Means ± SEM for unregulated (no 
Tn/Tm) actin filament velocities in the in vitro motility assay using myosin isolated from 
the corresponding condition. The myosin used was isolated from tissue from control, 
ischemia with 2 hours of reperfusion (IR2), and ischemia without resuscitation (IDNR). 
Data were analyzed using a Kruskal-Wallis ANOVA, but all comparisons were non-
significant (p>0.05). 
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Figure 7. Representative chromatograph from myosin purification over an HIC 
column. The isolated myosin from porcine myocardium was additionally purified using 
HIC based on a previously described methodology [Malmqvist et al.,  2004] with minor 
modifications (see Methods). Chromatograph displays absorbance at 280nm vs. elution 
volume. Proteins with minimal affinity for the column elute at high (1.45M) AmSO4 
(first broad peak). After the AmSO4 is reduced to 1.2M myosin is released (large narrow 
peak). This process removed impurities including actin and likely Tm, selecting for 
myosin and its light chains (Essential Light Chain, Regulatory Light Chain) as shown by 
SDS-PAGE gel (inset). 
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Figure 8. Purification with HIC column enhances Vactin. Further purification of the 
myosin using an HIC column nearly doubled Vactin from both Control tissue and tissue 
exposed to ischemia with 2 hours of reperfusion (IR2) (P<0.001). However, there was no 
difference between conditions with either the isolated myosin or the HIC purified 
myosin. 
 
 
Cardiac myosin was purified via an HIC column as it may be less stable than 
skeletal myosin and possibly the ischemia increased this instability. Control and IR2 
myosin samples were run over the column [Fig 7] and the resultant data displayed that 
the purification enhanced velocity to nearly double the velocity of both samples [Fig 8]. 
However, both samples were improved and were not significantly different from each 
other, which suggests that the column likely removed impurities and myosin that poorly 
hydrolyzes ATP [Malmqvist et al.,  2004] in earlier peaks than the eluted myosin sample. 
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The proteins eluted before the myosin sample were present in all samples, but the 
quantity was not affected by the ischemia/reperfusion protocol. It appeared that myosin’s 
function in the in vitro motility assay was unaffected by our model of 
ischemia/reperfusion.  
 
 
Figure 9. Effect of ischemia/reperfusion on NTF velocities (VNTF). Means ± SEM for 
native thin filament velocities in the in vitro motility assay using myosin isolated from 
the control tissue sample. The NTF used was isolated from control, ischemia with 2 h of 
reperfusion (IR2), and ischemia without resuscitation (IDNR). Data analyzed using a 
non-parametric Kruskal–Wallis ANOVA and indicated that IDNR was significantly 
greater than control velocity *, (p < 0.05). The data represent the average actin filament 
velocities from 20 to 30 s videos from Control, 19 from IR2 and 16 from IDNR.  
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Regulatory proteins may be vulnerable during ischemia [Gao et al.,  1997  ,  
McDonough et al.,  1999] and so we determined the velocity of these NTF isolated from 
each condition. At pCa 4 control and IR2 NTF samples had identical velocities [Fig 9  ,  
Fig 10], however IDNR samples moved significantly faster at 25% (p<0.05) greater than 
the control value [Fig 9]. The increased average velocity cannot be due to a decrease in 
moving filaments, because the percentage of moving filaments was similar for each 
condition. This suggests that the IDNR condition had some modification to the regulatory 
proteins Tn/Tm that regulate myosin’s interaction with actin 
This regulation is Ca2+ dependent, so one can measure the velocity as a function 
of Ca2+ and so we determined the Ca2+ sensitivity [Fig 10], which was plotted as the 
concentration of free Ca2+in solution expressed as pCa. The IDNR NTF sample had a 
significantly increased Ca2+ sensitivity (pCa50 6.57±0.04) compared to the control 
(6.34±0.07) and IR2 (6.47±0.13) [Fig 10A  ,  Table 1]. pCa50 is a measure of the Ca2+ 
concentration required to achieve half maximal activation of the filament and the IDNR 
sample had an increased pCa50, because it activated at a lower Ca2+ concentration than 
the other 2 samples and thus is more “sensitive” to [Ca2+]. Although not statistically 
significant, the Hill coefficient was increased in IDNR samples, which suggested the 
myosin and IDNR NTF sample seemed to have more cooperative binding compared to 
control filaments. A higher Hill coefficient suggested that there is a cooperative 
relationship between the binding of the ligand (exposed myosin binding site on actin) and 
its enzyme (myosin) and a subsequent increase in the affinity of the enzyme for the 
ligand (increased likelihood of a separate myosin molecule to interact with actin). We 
then used quantitative mass spectrometry to determine what structural modifications may 
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have occurred to Tn or Tm to induce this significant functional change only in the IDNR 
sample.  
 
 
Figure 10. Velocity-pCa data. A, NTF velocity (VNTF) plotted as a function of free 
[Ca2+] in –log units (pCa). Thin filaments from Control tissue are plotted with filled black 
dots and solid line, IR2 thin filaments with gray diamonds and solid gray line and the 
filaments from IDNR are plotted with dark gray boxes and a dashed gray line. Points 
represent mean ± SEM and the data were fit with the Hill equation (see Methods). * 
indicates significantly (p<0.05) different from WT VNTF. B, percentage of NTF moving 
as a function of free [Ca2+] symbols and lines same as in A. C, Motility index, defined as 
the product of VNTF and percent moving plotted as a function of free [Ca2+].  
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Table 1. Parameters for velocity-pCa fits to the Hill eq. VNTF indicates NTF velocities 
for filaments isolated from non-ischemic control, ischemia followed by 2 hrs of 
reperfusion (IR2) and ischemia followed by failed resuscitation (IDNR). n represents the 
Hill coefficient. Values represent mean ± SEM. * indicates significantly (p<0.05) 
different from Control tissue.  
 
 
No Truncation of Troponin I 
One of the most frequently observed structural changes associated with ischemia 
is the proteolytic cleavage of the C-terminal end of TnI [Westfall and Solaro,  1992  ,  
Gao et al.,  1997  ,  van Eyk et al.,  1998  ,  McDonough et al.,  1999  ,  van Eyk and 
Murphy,  2001]. We therefore used a mass spectrometry based, mass-balance approach to 
determine if the C-terminus of TnI was truncated during ischemia. We measured the 
relative abundance of the sum of the C-terminal 195NIDALSGMEGR205 (m/z = 581.78) 
and 195NIDALSGm*EGR205 (m/z = 589.77) peptides in the control and experimental 
samples that would be removed by ischemia induced proteolytic cleavage. The area under 
the LC peak for the C-terminal peptide was normalized using the TnI reference peptides 
used for the quantification of phosphorylation. The abundance of the C-terminal peptide 
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did not differ for either group [1.09 ± 0.19 (IR2), 1.06 ± 0.26 (IDNR)] when compared to 
controls. This lack of difference suggests that the C-terminus of TnI was not truncated as 
a result of the ischemic treatments employed in the present study.  
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Figure 11. LC elution profiles and data dependent MS2 spectra for TnI peptides. A, 
Representative LC elution profiles for the non-phosphorylated 23SSANYR28 (red), 
mono-phosphorylated 22RSSpANYR28 (grey) and bis-phosphorylated 
21RRSpSpANYR28 (black) peptides. Data dependent MS2 spectra for the B, mono-
phosphorylated 22RSSpANYR28 and C, bis-phosphorylated 21RRSpSpANYR28 
peptides showing fragment ions used for peptide identification and localization of 
phosphate. 
 
 
Quantification of Phosphorylation 
Peptides containing phosphate including: the mono-phosphorylated 
22RSSpANYR28 (m/z = 467.20R) and bis-phosphorylated 21RRSpSpANYR28 (m/z = 
585.23) peptides coming from TnI [Fig 11]; and 269AISEELDHALNDMTSpI284 (m/z = 
919.89), 269AISEELDHALNDm*TSpI284 (m/z = 927.89), and 
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269AISEELDHALNDm^TSpI284 (m/z = 935.89) peptides coming from α-Tm were 
identified in the data dependent MS2 spectra and manually confirmed [Previs et al.,  2008  
,  Weith et al.,  2012]. (It should be noted that Sp represents phosphoserine and m* and 
m^ denote methionine sulfoxide and sulphone). The degree of phosphorylation at these 
sites was determined via a mass-balance approach [Previs et al.,  2008  ,  Weith et al.,  
2012] from the abundance of the non-phosphorylated analogues of these phosphopeptides 
in each sample prior to and after the removal of phosphate with alkaline phosphatase. The 
non-phosphorylated analogues were the properly cleaved 23SSANYR28 peptide and the 
sum of the ion currents for the 269AISEELDHALNDMTSI284, 
269AISEELDHALNDm*TSI284 and 269AISEELDHALNDm^TSI284 peptides. 
Whereas this mass-balance approach is an indirect way to measure phosphorylation 
levels, it provides accurate quantification of the fraction of the protein molecules in a 
sample which are phosphorylated and obviates problems with quantification arising from 
mis-cleavage when the phosphate is proximal to the tryptic cleavage site [Previs et al.,  
2008]. For quantification, measured ion currents corresponding to peptides of interest 
were extracted from the LC chromatogram and the area under each LC peak was 
normalized using reference peptides within each sample to account for difference in the 
total amount of protein loaded onto the gel [Previs et al.,  2008  ,  Weith et al.,  2012]. 
The area under each LC peak for the TnI peptides of interest were normalized using the 
YDVEAK(m/z = 362.67), KLQLK (m/z = 629.43), ETLDLR (m/z = 746.40), 
NITEIADLNQK(m/z = 629.83), and IFDLR (m/z = 332.19) peptides; and the area under 
each LC for α-Tm peptides of interest were normalized using the HIAEDADR(m/z = 
 45 
 
463.72), SLEAQAEK (m/z = 438.22), IQLVEEELDR (m/z = 622.33), LVIIESDLER 
(m/z = 593.83), and SIDDLEDELYAQK(m/z = 769.86) peptides as references.  
 
 
 
Figure 12. Quantification of TnI and α-Tm phosphorylation. A, Percent 
phosphorylation of TnI serines 23 and/or 24 and Tm serine 283 in NTF isolated from 
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control hearts, and hearts following global ischemia that did not survive attempted 
resuscitation (IDNR) or survived and were then subject to 2 hours of reperfusion (IR2). 
B, Levels of mono- (serine 24) and bis-phosphorylated (serines 23 and 24) TnI relative to 
the control. * p < 0.01 relative to control and ^ p < 0.01 relative to IDNR. 
 
 
The overall percent phosphorylation of both TnI at serines 23/24 and αTm at 
serine 283 was significantly enhanced with respect to the control [Fig 12A] in samples 
from successful resuscitation followed by 2 hours of reperfusion (IR2). In contrast, the 
overall levels of TnI and Tm phosphorylation of samples from the failed resuscitation 
(IDNR) did not significantly differ from the control samples [Fig 12A]. However, this 
method of quantification is not sensitive to changes in site-specific phosphorylation when 
multiple phosphorylation sites are located within a single peptide, as was the case for TnI 
serine 23/24. Therefore, we determined if there was a shift in the phosphorylation profile 
between the mono- and bis-phosphorylated states by calculating the relative abundance of 
the mono-phosphorylated 22RSSpANYR28 and bis-phosphorylated 21RRSpSpANYR28 
peptides in each sample [Fig 12B]. We observed significant reductions in the abundance 
of the mono-phosphorylated peptides (0.27 ± 0.10 (IR2) and 0.19 ± 0.04 (IDNR)) and 
corresponding increases in the abundance of the bis-phosphorylated peptides (4.2 ± 1.3 
(IR2) and 2.8 ± 0.7 (IDNR)) with respect to the controls following the bout of ischemia 
regardless of survival [Fig 12B]. Therefore, under both ischemic conditions we observed 
in increase in the relative abundance of the bis-phosphorylated TnI 21RRSpSpANYR28 
peptide with respect to the control.   
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CHAPTER V 
DISCUSSION 
In vitro Function of the Contractile Proteins 
 This study attempted to discover what structural and functional effects occurred to 
the major contractile proteins following global myocardial ischemia and reperfusion. The 
in vitro motility assay revealed no difference in labeled actin filament velocity for cardiac 
myosin samples in either IR2 or IDNR conditions compared to the control [Fig 6]. As 
there was no difference in myosin’s ability to translocate actin, any modifications present 
were unlikely to have caused the depressed function others have seen in different studies. 
Thus no further experiments were performed to determine if there were any structural 
modifications to myosin. Other studies have used different ischemia paradigms, such as 
ligation of blood vessels inducing local ischemia, which has been shown to cause 
modifications by the production of ROS during ischemia [Zweier et al.,  1989]. The ROS 
can cause modifications to contractile proteins [Bolli and Marban,  1999] and affect 
myosin’s ATPase [Tiago et al.,  2006] and the ability to produce force in vitro and 
translocate actin [Rao et al.,  2007]. Other studies also employed longer periods of 
ischemia (up to 60 minutes) and subsequent reperfusion of the heart for 24-72 hours. The 
different protocols for inducing ischemia, as well as the durations of induced ischemia 
and reperfusion could be the reason for the lack of observed changes to myosin. This 
study had an ischemic bout of 12 minutes due to the rarity of the animal surviving a bout 
longer than 15 minutes, which would not allow for any reperfusion due to a failure to 
revive the animal (>50% fail to resuscitate) [Kern et al.,  1996]. Others have studied the 
heart in a Langendorff apparatus [van Eyk et al.,  1998  ,  McDonough et al.,  1999], but 
 48 
 
our study kept the heart in vivo during both the ischemic and reperfusion periods until 
excision of the heart tissue upon conclusion of 12 minutes ischemia with or without 
reperfusion. This short timeframe of 12 minutes applies more directly for the typical 
timeframe of approximately 8 minutes for human cases of out-of-hospital sudden cardiac 
arrest [Cobb et al.,  1999]. A longer ischemic bout may lead to the changes other studies 
have seen, but would likely not result in ROSC and not be relevant to real human 
emergency cases with such rapid EMT unit response times.  
 
Modifications to the Regulatory Proteins 
Degradation of TnI is one of the most common modifications resulting from 
ischemia/reperfusion especially in localized ischemic episodes, but we did not observe 
any significant TnI degradation in this study. Proteolytic cleavage of TnI’s C-terminus 
has been seen in many models and longer bouts of ischemia is positively correlated with 
greater levels of cleavage [Gao et al.,  1997  ,  McDonough et al.,  1999  ,  Foster et al.,  
2003  ,  Westfall and Solaro,  1992  ,  Day et al.,  2007  ,  van Eyk et al.,  1998  ,  Van 
Eyk and Murphy,  2001]. This TnI truncation alters its ability to interact with TnC and 
any alteration to this interaction can have drastic impacts on activation of the thin 
filament, which has been suggested as part of ischemia-induced contractile dysfunction 
[Gao et al.,  1997  ,  McDonough et al.,  1999]. This truncation may alter the muscle’s 
ability to produce force and its Ca2+ sensitivity, which can lead to enhanced or even 
diminished ability to respond to normal Ca2+ levels [Westfall and Solaro,  1992  ,  van 
Eyk et al.,  1998  ,  van Eyk and Murphy,  2001  ,  Foster et al.,  2003  ,  Day et al.,  
2007]. This cleavage, when severe enough, has been shown to influence the position of 
 49 
 
Tm on actin such that it increases the probability of myosin binding to actin [Galinska et 
al.,  2010]. SDS-PAGE staining was inconclusive (data not shown) and so mass 
spectrometry was expected to have a greater resolution for detecting cleavage. Data 
acquired via LC-MS suggested that there was no difference in TnI truncation between the 
samples [Fig 11]. This lack of cleavage may also be attributed to the brevity of ischemia 
in this study, because other studies with 15-60 minute ischemic bouts had increasing 
amounts of truncation the longer the ischemia occurred [Westfall and Solaro,  1992  ,  
Gao et al.,  1995  ,  Gao et al.,  1997  ,  van Eyk et al.,  1998]. In addition, the type of 
ischemia is important because artery occlusion is a more localized ischemia and removal 
of the heart into a Langendorff apparatus is a different type of “global” ischemia for the 
heart, because the whole heart is removed from the animal.  
Previous studies suggested other common modifications such as oxidative 
modifications, but there were no significant differences in oxidative changes to proteins 
between any of the samples in our study (data not shown). However, we discovered that 
there was an increase in bis-phosphorylation of Ser23 and 24 in both experimental 
ischemia TnI samples [Fig 12B] and there was an increase in phosphorylation of α-Tm 
only in IR2 pig samples [Fig 12A]. Unexpectedly, only the IDNR sample tissue resulted 
in significantly altered thin filament Ca2+ sensitivity and maximal filament velocity [Fig 9  
,  Fig 10  ,  Table 1]. The increased maximal sliding velocities and Ca2+ sensitivity seen 
in IDNR samples occurred with only an increase in the bis-phosphorylation of TnI 
Ser23/24, but this enhanced velocity was lost in the reperfused IR2 sample where there 
was found to also be an increased level of α-Tm phosphorylation [Fig 12]. Other research 
supports the possibility that phosphorylation of TnI may allow Tn to be more sensitive to 
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Ca2+ and Tm phosphorylation can change the interaction of Tm monomers and thus 
activation of the thin filament [Rao et al.,  2009]. However, there are conflicting reports 
of phosphorylation status of regulatory proteins after ischemia as some studies have seen 
an increase in phosphorylation of TnI and α-Tm [Han and Ogut,  2010  ,  Han and Ogut,  
2011] while other have found no change in PO4 [Rao et al.,  2007]. 
Conclusion 
This study was designed to elucidate the underlying structural and functional 
changes to myocardial contractile proteins caused by global ischemia and reperfusion 
injury due to sudden cardiac arrest. Our data contradicted the original hypothesis that 
there would be a decrease of the in vitro velocity in samples that underwent 
ischemia/reperfusion and that this would be due to post-translational modifications to 
myosin with little or no damage to actin. There was no difference in sliding velocity for 
across any of the samples when using cardiac myosin with unregulated actin [Fig 6  ,  Fig 
8]. No mass spectrometry was performed because there were no functional effects 
observed without using the NTF from the samples [Fig 6  ,  Fig 8]. There may have been 
alterations to myosin, but in this case none that would be relevant to the scope of this 
study.  
Our original hypothesis predicted that ischemia/reperfusion would affect Ca2+ 
sensitivity of NTF due to cleavage/modifications of Tn. This hypothesis was determined 
to be partly true, because the IR2 sample was not significantly different from control for 
either myosin or NTF samples, however the IDNR NTF samples had a significant 
increase in maximal sliding velocity and increase Ca2+ sensitivity [Fig 9  ,  Fig 10  ,  
Table 1]. Also mass spectrometry was performed on regulatory proteins to quantify the 
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amount of modifications that occurred to the proteins and the TnI in IDNR and IR2 
samples had more bis-phosphorylated TnI compared to control, but only the IR2 sample 
had an increase in Tm phosphorylation [Fig 12]. Our results agreed with the original 
hypothesis as there was an increase in Ca2+ sensitivity that may have been due to an 
increase in phosphorylation of TnI, but an unexpected increase in Tm phosphorylation 
could have mitigated this increase. However, there was no significant cleavage of TnI, 
although several previous studies have implicated this cleavage as a key player in 
functional changes due to ischemia/reperfusion [Westfall and Solaro,  1992  ,  Gao et al.,  
1997  ,  van Eyk et al.,  1998  ,  McDonough et al.,  1999  ,  van Eyk and Murphy,  2001]. 
One study had displayed that phosphorylating TnI with PKA then combining with the 
rest of the filament proteins into reconstituted thin filament (RTF) increased Ca2+ 
sensitivity and velocity in the in vitro motility assay [Hunlich et al.,  2005]. This supports 
that TnI phosphorylation can alter velocity and Ca2+ sensitivity such as displayed in our 
study, however there are inconsistencies across studies of whether TnI phosphorylation 
increases or decreases velocity [Marston and de Tombe,  2008]. Our findings could 
suggest that the changes in phosphorylation, increased Ca2+ sensitivity, and sliding 
velocity may be due to a compensatory mechanism in the heart attempting to increase 
contractility. This phosphorylation mechanism may adversely affect cardiac function 
depending on the extent of this phosphorylation and which regulatory proteins are 
affected.  
Our findings were different when compared to several other studies likely due to 
the different techniques, animal models, and timeframes employed for the experimental 
ischemia/reperfusion. Acquiring more samples from different animals with varying 
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ischemia/reperfusion times may have allowed us to determine the relation between the 
duration of the ischemic event with the different modifications seen in other studies. 
Another aspect not included in this study was investigating if there were alterations to the 
thick filament. Studies have shown thick filament alterations can have affects as well, 
such as phosphorylation of myosin binding protein-C, which is needed for proper cardiac 
function and if altered could lead to certain cardiomyopathies [Sadayappan et al.,  2005]. 
Different myosin binding protein-C phosphorylation states have been implicated in 
altering Ca2+ sensitivity and maximal sliding velocities [Previs et al.,  2012], loaded 
shortening and power output [Korte et al.,  2003], and also can be truncated during 
ischemia similar to TnI [Sadayappan,  2012]. There can be many things that lead to 
persistent contractile dysfunction and poor prognosis after ROSC following sudden 
cardiac arrest, but this study displayed that there were post-translational phosphorylation 
on muscle regulatory proteins that altered their function in vitro.  
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